FDA Inspection 1034633 — SGS Canada Inc

SGS Canada Inc — FEI 3007632373

The FDA completed an inspection of SGS Canada Inc on December 12, 2017 in Mississauga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 12, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mississauga (Canada)

Citations

IDCFRDescription
180921 CFR 211.160(a)Following/documenting laboratory controls
202721 CFR 211.192Investigations of discrepancies, failures